169 related articles for article (PubMed ID: 3279118)
1. Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-beta 2, and is inhibited by specific antibodies to IFN-beta.
Reis LF; Le JM; Hirano T; Kishimoto T; Vilcek J
J Immunol; 1988 Mar; 140(5):1566-70. PubMed ID: 3279118
[TBL] [Abstract][Full Text] [Related]
2. The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor.
Van Damme J; De Ley M; Van Snick J; Dinarello CA; Billiau A
J Immunol; 1987 Sep; 139(6):1867-72. PubMed ID: 3305707
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines.
Walther Z; May LT; Sehgal PB
J Immunol; 1988 Feb; 140(3):974-7. PubMed ID: 3276786
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
5. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
Redlich PN; Grossberg SE
J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
[TBL] [Abstract][Full Text] [Related]
6. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
[TBL] [Abstract][Full Text] [Related]
7. Antiviral effects of recombinant human tumor necrosis factor.
Ito M; O'Malley JA
Lymphokine Res; 1987; 6(4):309-18. PubMed ID: 2448553
[TBL] [Abstract][Full Text] [Related]
8. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas.
Kawano M; Hirano T; Matsuda T; Taga T; Horii Y; Iwato K; Asaoku H; Tang B; Tanabe O; Tanaka H
Nature; 1988 Mar; 332(6159):83-5. PubMed ID: 3258060
[TBL] [Abstract][Full Text] [Related]
9. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.
Matsuda T; Hirano T; Kishimoto T
Eur J Immunol; 1988 Jun; 18(6):951-6. PubMed ID: 3260187
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line.
Le J; Reis LF; Vilcek J
Lymphokine Res; 1988; 7(2):99-106. PubMed ID: 3261383
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin-1, and epidermal growth factor in human fibroblasts.
Kohase M; Henriksen-Destefano D; Sehgal PB; Vilcek J
J Cell Physiol; 1987 Aug; 132(2):271-8. PubMed ID: 3040777
[TBL] [Abstract][Full Text] [Related]
12. Induction of hybridoma growth factor (HGF), identical to IL-6, in human fibroblasts by IL-1: use of HGF activity in specific and sensitive biological assays for IL-1 and IL-6.
Van Damme J; Van Snick J
Dev Biol Stand; 1988; 69():31-8. PubMed ID: 3265677
[TBL] [Abstract][Full Text] [Related]
13. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.
Kirnbauer R; Köck A; Schwarz T; Urbanski A; Krutmann J; Borth W; Damm D; Shipley G; Ansel JC; Luger TA
J Immunol; 1989 Mar; 142(6):1922-8. PubMed ID: 2784142
[TBL] [Abstract][Full Text] [Related]
14. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells.
Coffman RL; Ohara J; Bond MW; Carty J; Zlotnik A; Paul WE
J Immunol; 1986 Jun; 136(12):4538-41. PubMed ID: 3486902
[TBL] [Abstract][Full Text] [Related]
15. Absence of antiviral activity in recombinant B cell stimulatory factor 2 (BSF-2).
Hirano T; Matsuda T; Hosoi K; Okano A; Matsui H; Kishimoto T
Immunol Lett; 1988 Jan; 17(1):41-5. PubMed ID: 2832321
[TBL] [Abstract][Full Text] [Related]
16. B cell stimulatory factor 1 induces lobster agglutinin 1-separated mouse thymocytes to express cytotoxic T lymphocyte activity.
Collins JM; Justement LB; Stedman KE; Zlotnik A; Campbell PA
J Immunol; 1988 Jul; 141(1):145-50. PubMed ID: 3259965
[TBL] [Abstract][Full Text] [Related]
17. The effect of enhancing antibodies on TNF interactions with its specific receptor: consequences for in vitro TNF antiviral activity.
Lidbury BA; Rathjen DA; Ramshaw IA; Cowden WB
Biotechnol Ther; 1994; 5(1-2):27-45. PubMed ID: 7703831
[TBL] [Abstract][Full Text] [Related]
18. Regulation of murine plasmacytoma transferrin receptor expression and G1 traversal by plasmacytoma cell growth factor.
Neckers LM; Nordan RP
J Cell Physiol; 1988 Jun; 135(3):495-501. PubMed ID: 3260898
[TBL] [Abstract][Full Text] [Related]
19. Production of BSF-1 during an in vivo, T-dependent immune response.
Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
[TBL] [Abstract][Full Text] [Related]
20. High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells.
Coulie PG; Vanhecke A; Van Damme J; Cayphas S; Poupart P; De Wit L; Content J
Eur J Immunol; 1987 Oct; 17(10):1435-40. PubMed ID: 3500055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
